IV infusion are used for administration of antipyretics, antibiotics, and analgesics, and can be used for longer period of time for frequent intake of drugs in hospital settings. The infusion therapies include antibiotic/antiviral therapy, anti-coagulation therapy, anti-emetics, chemotherapy, and total parenteral nutrition. The seals and caps for the IV infusion bottle are classified on the bases of neck size, which include up to 20 mm, 21 to 28 mm, 29 to 32 mm, and above 32 mm.
Rising incidence of cancer and other chronic diseases is a major factor that is expected to boost the IV infusion bottle seals & caps market growth over the forecast period. For instance, according to the GLOBOCAN, in 2018, an estimated 43.6% new cases of breast cancer in Asia Pacific were registered. Moreover, according to the American Cancer Society, 2017, cancer was the second most common cause of death in the U.S., which accounted for nearly 1 out of every 4 deaths. Key players are focusing on investing, in order to build manufacturing facilitywhich is expected to drive the IV infusion bottle seals & caps market growth. For instance, in 2019, Sandeep Toshniwal, CEO, Eurolife Healthcare announced about the investment of around US$ 58 Mn, in order to build the intravenous infusion plant in India.
- This report provides in-depth analysis of the global IV infusion bottle seals & caps market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global IV infusion bottle seals & caps market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Cardinal Health Inc., Jiangsu changjiang Lids, Taiwan Hon Chuan Enterprise, PrasadMeditech, Winfield Laboratories Inc., Datwyler HoldingAG, Wuxi Qitian Medical Technology Co., Ltd, Medline Industries Inc., RENOLITSE, and B. Braun Medical Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future launches, market expansion, and marketing tactics
- The global IV infusion bottle seals & caps market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global IV infusion bottle seals & caps market
-
- Polypropylene Caps
- Rubber Seals
-
- Up to 20 mm
- 21 to 28 mm
- 29 to 32 mm
- Above 32 mm
-
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
-
- Cardinal Health Inc.
- Jiangsu Changjiang Lids
- Taiwan Hon Chuan Enterprise
- PrasadMeditech
- Winfield Laboratories Inc.
- Datwyler Holding AG
- Wuxi Qitian Medical Technology Co., Ltd
- Medline Industries Inc.
- RENOLIT SE
- Braun Medical Inc.
